Similar sites
Category
EmailGlobal Rank
N/ARank in 1 month
99.4KEstimate Value
N/Aschütze dich vor spam! ✔kostenlos & anonym ✔empfang von emails mit anhang ✔antworten, weiterleiten & versenden von emails ➔ viele domains!
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#pdf タイトル 文字化け
#pdf タイトル 変更
#園児 プール開き
#pdf 名前変更
#pdf タイトル変更
#泡 css
#transition opacity
#all in one seo サイトマップ エラー
#マウスオーバー css
#wordpress 固定ページ html 埋め込み
#エクセル 文字化け
#excel 文字化け
#facebook url
#gmail 迷惑メールにしない
#facebook 自分のurl
#進行表
#進行表 テンプレート
#タイムテーブル 作成
#イベント 進行表 テンプレート
#タイムテーブル テンプレート
#microsoft store 再インストール
#windows10 miracast 有線lan
#vba 配列には割り当てられません
#手が小さい キーボード
Malware Scan Info
Macafee Check :
Email address with tempriantherapeutics.com
Recent Searched Sites
Link12bet.club (2 mins ago) / US
Accuracyiseverything.com (8 seconds ago) / HK
Muzik-hotel-ximen-station-branch-taipei.hotelmix.co.th (46 seconds ago) / US
Pullman-paris-montparnasse-hotel.booked.net (28 seconds ago) / US
Hi-way.co.za (1 mins ago) / ZA
Online.pdp.uz (2 seconds ago) / US
Best-handyman-services-nyc.dtfinderfg.com (59 seconds ago) / US
Ainiti.org (51 seconds ago) / US
Townofboulderjunction.org (7 seconds ago) / US
Greatamericanspaces.com (13 seconds ago) / US
Choosy.ie (55 seconds ago) / IE
Roissy-chambres-bed-breakfast.hotelmix.fr (1 mins ago) / US
Zjchjt.cn.b2b168.com (13 seconds ago) / CN
Ahjkii.pingcode.com (58 seconds ago) / CN
Numizon.com (42 seconds ago) / IE
Zjcxs.wenming.cn (20 seconds ago) / US
Tempriantherapeutics.com (3 seconds ago) / US
Pirec.org (6 seconds ago) / US
Projectgolfau.com (27 seconds ago) / US
Docs.securestate.vmware.com (15 seconds ago) / US
Domain Informations
Tempriantherapeutics.com lookup results from whois.godaddy.com server:
- Domain created: 2018-12-21T03:18:54Z
- Domain updated: 2023-12-14T03:20:30Z
- Domain expires: 2024-12-21T03:18:54Z 0 Years, 163 Days left
- Website age: 5 Years, 201 Days
- Registrar Domain ID: 2345292614_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS2.WIXDNS.NET
- NS3.WIXDNS.NET
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 680673 |
namecheap.com | 224815 |
networksolutions.com | 166289 |
tucows.com | 137788 |
publicdomainregistry.com | 87644 |
whois.godaddy.com | 62197 |
enomdomains.com | 58093 |
cloudflare.com | 50063 |
namesilo.com | 48725 |
gmo.jp | 46243 |
register.com | 38933 |
fastdomain.com | 38170 |
ionos.com | 33870 |
name.com | 32166 |
wildwestdomains.com | 32165 |
net.cn | 30887 |
registrar.amazon.com | 30450 |
dynadot.com | 28168 |
key-systems.net | 27147 |
Host Informations
Host name | unalocated.63.wixsite.com |
IP address | 185.230.63.171 |
Location | Ashburn United States |
Latitude | 39.018 |
Longitude | -77.539 |
Metro Code | 511 |
Timezone | America/New_York |
Postal | 20147 |
Port Scanner (IP: 185.230.63.171)
Spam Check (IP: 185.230.63.171) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Site Inspections
Websites Listing
We found Websites Listing below when search with tempriantherapeutics.com on Search Engine
Temprian Therapeutics
Temprian Therapeutics is developing a new way to treat vitiligo by injecting DNA coding for a modified heat shock protein HSP70i to stop the autoimmune response at the outset. We are now looking for investments and donations to get clinical trials off the ground.
Tempriantherapeutics.comDA: 24 PA: 24 MOZ Rank: 25
Temprian Therapeutics: developing a gene-based …
Temprian Therapeutics is a spin-off from Northwestern University in Chicago, Illinois. Vitiligo is an autoimmune disease that affects …
Nature.comDA: 14 PA: 28 MOZ Rank: 43
Tempest Therapeutics | Targeted and Immune-Mediated …
April 27, 2022. Tempest Announces Oral and Poster Presentations at the Upcoming 2022 ASCO Annual Meeting. April 27, 2022. Tempest Announces Private Placement Financing of $15 Million. April 8, 2022. Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting. More news.
Tempesttx.comDA: 17 PA: 17 MOZ Rank: 20
Xalud Therapeutics | Gene Therapy Company | United States
Xalud is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud’s lead product candidate, XT-150, is a locally-injectable plasmid DNA gene therapy expressing ...
Xaludthera.comDA: 18 PA: 18 MOZ Rank: 22
Toast Distillers
First Response . All rights reserved to Toast Distillers, Incorporated.
Toastdistillers.comDA: 23 PA: 23 MOZ Rank: 28
Teak Tea | Teak Tea - Teak Tea - High Quality Teas with a Mission: …
Teak Tea 24 Pack. Isaac L. 11/2/2020. Great natural tea with a hint of sweetness. I love to drink it cold during lunch and the small amount of caffeine helps me get thru the rest of my day. It also plants trees! Can't go wrong with either flavors. Teak Tea 24 Pack.
Teakteas.comDA: 12 PA: 12 MOZ Rank: 18
Temprian Therapeutics - Crunchbase Company Profile & Funding
Temprian Therapeutics is a developer of therapies intended for autoimmune disease. The company offers DNA-based treatment by injecting DNA coding for a modified heat shock protein to stop the autoimmune response at the outset, enabling consumers to get treatments for vitiligo disease. Lists Featuring This Company
Crunchbase.comDA: 18 PA: 35 MOZ Rank: 59
Temprian Therapeutics Finalist in Nature Merck Spinoff 2020
ABOUT Temprian Therapeutics Inc. The company is a spinoff from Northwestern University, established to develop DNA based treatments for autoimmune disease. Its lead indication is vitiligo. The Company has worked closely with the patient community in the development of a safe, non-invasive, market-oriented treatment for vitiligo.
Prweb.comDA: 13 PA: 50 MOZ Rank: 43
Temprian Therapeutics - Posts | Facebook
Temprian Therapeutics August 4 · Temprian is happy to share that the study “HSP70iQ435A to subdue autoimmunity and support anti-tumor responses" has been accepted for publication in Cell Stress & Chaperones. Here the Le Poole Lab out of Northwestern shows a supportive role for HSP70iQ435A in anti-tumor responses.
Facebook.comDA: 16 PA: 28 MOZ Rank: 52
Temprian Therapeutics, Inc. in Dover, DE | Company Info & Reviews
Temprian Therapeutics, Inc. is a Delaware Domestic Corporation filed On January 2, 2019. The company's filing status is listed as Active and its File Number is 7219414. The Registered Agent on file for this company is Cogency Global Inc. and is located at 850 New Burton Road Suite 201, Dover, DE 19904.
Bizapedia.comDA: 17 PA: 34 MOZ Rank: 60
Nature selects Temprian Therapeutics as a finalist for their Spinoff ...
ABOUT Temprian Therapeutics Inc. The company is a spinoff from Northwestern University, established to develop DNA based treatments for autoimmune disease. Its lead indication is vitiligo. The Company has worked closely with the patient community in the development of a safe, non-invasive, market-oriented treatment for vitiligo. The HSP70-based ...
2floventures.comDA: 16 PA: 50 MOZ Rank: 40
Temprian Therapeutics - Overview, News & Competitors
View Temprian Therapeutics (www.tempriantherapeutics.com) location in Illinois, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.
Zoominfo.comDA: 16 PA: 38 MOZ Rank: 65
TGTX Stock Price | TG Therapeutics Inc. Stock Quote (U.S.: Nasdaq ...
TGTX | Complete TG Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Marketwatch.comDA: 19 PA: 21 MOZ Rank: 52
Temprian Therapeutics: developing a gene-based treatment for …
Temprian Therapeutics: developing a gene-based treatment for vitiligo Nature. 2020 Jun 30. doi: 10.1038/d41586-020-01808-5. Online ahead of print.
Pubmed.ncbi.nlm.nih.govDA: 23 PA: 10 MOZ Rank: 46
Temprian Therapeutics Corporate Partnerships | CipherBio
Explore Temprian Therapeutics's partner organizations, latest news and browse their most connected people here!
Cipherbio.comDA: 17 PA: 50 MOZ Rank: 85
Temprian Therapeutics Finalist in Nature Merck Spinoff 2020 …
ABOUT Temprian Therapeutics Inc. The company is a spinoff from Northwestern University, established to develop DNA based treatments for autoimmune disease. Its lead indication is vitiligo. The...
Markets.businessinsider.comDA: 27 PA: 50 MOZ Rank: 35
Temprian Therapeutics | Fundable - Crowdfunding for Small …
Temprian Therapeutics is a biotech spin-off from Northwestern University. The company's technology is based on over 25 years of research in the areas of gene therapies, autoimmune diseases and dermatology from the labs of Professor Caroline Le Poole. The lead program is a platform technology to treat autoimmune diseases such as vitiligo.
Fundable.comDA: 16 PA: 22 MOZ Rank: 54
Temprian Therapeutics Company Profile: Valuation & Investors
Information on valuation, funding, cap tables, investors, and executives for Temprian Therapeutics. Use the PitchBook Platform to explore the full profile.
Pitchbook.comDA: 13 PA: 27 MOZ Rank: 57
Ashvattha Therapeutics - Crunchbase Company Profile & Funding
Founded Date 2015. Founders Jeffrey Cleland, Justin Hanes, Kannan Rangaramanujam, Sujatha Kannan. Operating Status Active. Last Funding Type Series B. Legal Name Ashvattha Therapeutics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 650-868-5853. Ashvattha Therapeutics creates products that selectively ...
Crunchbase.comDA: 18 PA: 36 MOZ Rank: 72
Ashvattha Therapeutics Company Profile: Valuation & Investors
Description. Developer of novel therapeutics platform designed to treat the unmet medical needs in oncology, ophthalmology, and inflammatory diseases. The company's platform consists of hydroxyl dendrimers that selectively target actively endocytosing cells such as reactive microglia and macrophages responsible for chronic inflammation and ...
Pitchbook.comDA: 13 PA: 27 MOZ Rank: 59
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
outandaboutuae.net | gname.com | 312 Days |
alphaomegaalpha.org | networksolutions.com | 3 Years, 70 Days |